Stemonix
CEO: Ping Yeh
StemoniX is a drug discovery and development service company which seeks to transform conventional drug development by creating pre-clinical plates containing human microOrgans®.
Engineered from human-induced pluripotent stem cells, these microOrgan® platforms enable human drug screening without the need for drugs to enter a human body. Starting with Microbrains, StemoniX is currently servicing companies doing drug discovery in brain health.
This capability has the potential to deliver significant cost and time savings to the pharmaceutical industry, allowing potentially life-changing drugs to get to patients in need more quickly.